ArticleHealthcare (Basel, Switzerland)2022

Donanemab for Alzheimer's Disease: A Systematic Review of Clinical Trials.

Areeba Rashad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.